Symbol="PTGX"
AssetType="Common Stock"
Name="Protagonist Therapeutics Inc"
Description="Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California."
CIK="1377121"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1129256000"
EBITDA="-145250000"
PERatio="None"
PEGRatio="0"
BookValue="4.202"
DividendPerShare="0"
DividendYield="0"
EPS="-2.68"
RevenuePerShareTTM="0.017"
ProfitMargin="0"
OperatingMarginTTM="-170.29"
ReturnOnAssetsTTM="-0.311"
ReturnOnEquityTTM="-0.541"
RevenueTTM="859000"
GrossProfitTTM="26581000"
DilutedEPSTTM="-2.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="39.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.27"
PriceToBookRatio="1.925"
EVToRevenue="5.84"
EVToEBITDA="-1.604"
Beta="1.937"
num_52WeekHigh="30.1"
num_52WeekLow="7.24"
num_50DayMovingAverage="25.5"
num_200DayMovingAverage="17.15"
SharesOutstanding="57251000"
DividendDate="None"
ExDividendDate="None"
symbol="PTGX"
open="19.34"
high="19.68"
low="19.10"
price="19.13"
volume="618708.00"
latest_trading_day="2023-07-26"
previous_close="19.36"
change="-0.23"
change_percent="-1.1880%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="17"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="83"
Volume_recent_avg="1512866"
Change_recent_avg="0.01"
Delta_recent_avg="1.38"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="83"
Aroon_momentum_negative="17"
image_negative_thumbnail_id_1="1146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0179.jpeg"
image_negative_thumbnail_id_2="493"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="985"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
